Astellas Pharma Shares Outstanding 2012-2019 | ALPMY

Astellas Pharma shares outstanding history from 2012 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Astellas Pharma shares outstanding for the quarter ending September 30, 2019 were M, a 100% decline year-over-year.
  • Astellas Pharma 2019 shares outstanding were 2.03B, a 0.11% decline from 2018.
  • Astellas Pharma 2018 shares outstanding were 2.032B, a 4.26% decline from 2017.
  • Astellas Pharma 2017 shares outstanding were 2.123B, a 1.78% decline from 2016.
Astellas Pharma Annual Shares Outstanding
(Millions of Shares)
2019 2,030
2018 2,032
2017 2,123
2016 2,161
2015 2,212
2014 2,247
2013 2,294
2012 2,340
2011 2,340
2010 2,380
2009 2,520
2008 2,595
2007 2,689
2006 2,819
Astellas Pharma Quarterly Shares Outstanding
(Millions of Shares)
2019-09-30
2019-06-30 1,888
2018-06-30 2,008
2017-06-30 2,066
2016-09-30 2,160
2016-06-30 2,127
2016-03-31 2,161
2015-12-31 2,170
2015-09-30 2,179
2015-06-30 2,190
2015-03-31 2,212
2014-12-31 2,216
2014-09-30 2,217
2014-06-30 2,223
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $29.371B $11.834B
Astellas Pharma, Inc. is engaged in the research, development, manufacturing and marketing of pharmaceuticals drugs. Products offered by the Company include Prograf applicable for the prevention of rejection in organ transplants, Vesicare for treatment of overactive bladder, Protopic for the treatment of atopic dermatitis in the topical immunomodulator class, Harnal to treat the functional symptoms of benign prostatic hyperplasia (BPH), including weak urinary stream, frequent nighttime urination, and sensation of incomplete emptying of the bladder and Fungard an antifungal agent. Astellas Pharma, Inc. is headquartered in Tokyo, Japan.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $60.217B 34.83
Takeda Pharmaceutical (TAK) Japan $48.868B 8.56
Eisai (ESALY) Japan $20.251B 37.73
UCB SA (UCBJF) Belgium $15.687B 0.00
Grifols, S.A (GRFS) Spain $13.311B 16.55
Merck (MKGAF) Germany $12.924B 16.95
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Neurocrine Biosciences (NBIX) United States $8.419B 233.90
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.874B 0.00
Catalent (CTLT) United States $7.671B 31.56
Ionis Pharmaceuticals (IONS) United States $7.164B 21.71
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.906B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $5.937B 7.24
Orion OYJ (ORINY) Finland $5.269B 23.61
STADA ARZNEIMI (STDAF) Germany $4.685B 0.00
IPSEN SA ADR (IPSEY) France $4.656B 0.00
Forty Seven (FTSV) United States $4.599B 0.00
United Therapeutics (UTHR) United States $4.202B 0.00
Evotec AG (EVTCY) Germany $3.580B 57.74
Hypermarcas (HYPMY) Brazil $3.462B 10.53
Nektar Therapeutics (NKTR) United States $3.207B 0.00
FibroGen (FGEN) United States $3.159B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.942B 54.60
PTC Therapeutics (PTCT) United States $2.816B 0.00
ChemoCentryx (CCXI) United States $2.682B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.440B 9.87
Xencor (XNCR) United States $1.805B 73.70
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.684B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.593B 19.36
USANA Health Sciences (USNA) United States $1.511B 15.86
Sage Therapeutics (SAGE) United States $1.473B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.467B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.345B 36.78
Corcept Therapeutics (CORT) United States $1.322B 14.80
Karyopharm Therapeutics (KPTI) United States $1.255B 0.00
Heron Therapeutics (HRTX) United States $1.155B 0.00
Zogenix (ZGNX) United States $1.047B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.012B 31.34
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.940B 13.08
Akebia Therapeutics (AKBA) United States $0.921B 0.00
Esperion Therapeutics (ESPR) United States $0.879B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.759B 0.00
Endo (ENDP) Ireland $0.728B 1.34
Molecular Templates (MTEM) United States $0.632B 0.00
Tilray (TLRY) Canada $0.620B 0.00
Translate Bio (TBIO) United States $0.620B 0.00
ImmunoGen (IMGN) United States $0.607B 0.00
Radius Health (RDUS) United States $0.603B 0.00
Collegium Pharmaceutical (COLL) United States $0.602B 0.00
Aerie Pharmaceuticals (AERI) United States $0.557B 0.00
Portola Pharmaceuticals (PTLA) United States $0.552B 0.00
Siga Technologies (SIGA) United States $0.432B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.411B 16.86
Indivior (INVVY) United States $0.408B 2.43
Catalyst Pharmaceuticals (CPRX) United States $0.405B 13.52
Innate Pharma SA (IPHYF) France $0.385B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.376B 0.00
Ardelyx (ARDX) United States $0.376B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.360B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.329B 0.00
Trillium Therapeutics (TRIL) Canada $0.329B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.316B 0.00
Organogenesis Holdings (ORGO) United States $0.315B 0.00
Calithera Biosciences (CALA) United States $0.307B 0.00
Flexion Therapeutics (FLXN) United States $0.299B 0.00
Harpoon Therapeutics (HARP) United States $0.296B 0.00
Lannett Co Inc (LCI) United States $0.294B 4.73
DURECT (DRRX) United States $0.284B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.271B 0.00
Ocular Therapeutix (OCUL) United States $0.271B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.268B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.262B 0.00
TherapeuticsMD (TXMD) United States $0.251B 0.00
Concert Pharmaceuticals (CNCE) United States $0.249B 0.00
Rafael Holdings (RFL) United States $0.207B 0.00
CASI Pharmaceuticals (CASI) United States $0.192B 0.00
Recro Pharma (REPH) United States $0.187B 0.00
OptiNose (OPTN) United States $0.179B 0.00
Jounce Therapeutics (JNCE) United States $0.169B 3.04
PROFOUND MEDICL (PROF) Canada $0.166B 0.00
MEI Pharma (MEIP) United States $0.165B 0.00
Nature's Sunshine Products (NATR) United States $0.157B 19.61
La Jolla Pharmaceutical (LJPC) United States $0.156B 0.00
Taiwan Liposome (TLC) Taiwan $0.136B 0.00
KalVista Pharmaceuticals (KALV) United States $0.135B 0.00
Redhill Biopharma (RDHL) Israel $0.123B 0.00
VAXART, INC (VXRT) United States $0.122B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.104B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.102B 0.00
CannTrust Holdings (CTST) Canada $0.090B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.087B 0.00
IMV INC (IMV) Canada $0.087B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.085B 0.00
SCYNEXIS (SCYX) United States $0.082B 0.00
Champions Oncology (CSBR) United States $0.079B 0.00
Hemispherx BioPharma (AIM) United States $0.079B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.076B 0.00
Xeris Pharmaceuticals (XERS) United States $0.075B 0.00
Aquestive Therapeutics (AQST) United States $0.071B 0.00
CTI BioPharma (CTIC) United States $0.071B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.069B 0.00
Biomerica (BMRA) United States $0.069B 0.00
CV Sciences (CVSI) United States $0.067B 0.00
Otonomy (OTIC) United States $0.061B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.055B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.054B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.054B 16.86
Nivalis Therapeutics (ALPN) United States $0.051B 0.00
Infinity Pharmaceuticals (INFI) United States $0.050B 0.00
Onconova Therapeutics (ONTX) United States $0.048B 0.00
Aclaris Therapeutics (ACRS) United States $0.048B 0.00
PharmAthene (ALT) United States $0.046B 0.00
Natural Alternatives (NAII) United States $0.045B 20.31
Sundial Growers (SNDL) Canada $0.044B 0.00
GTx (ONCT) United States $0.044B 0.00
MediWound (MDWD) Israel $0.041B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.040B 135.43
Neos Therapeutics (NEOS) United States $0.039B 0.00
Forward Pharma (FWP) Denmark $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
PolarityTE (PTE) United States $0.036B 0.00
AgeX Therapeutics (AGE) United States $0.035B 0.00
IsoRay (ISR) United States $0.034B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.031B 0.00
Heat Biologics (HTBX) United States $0.030B 0.00
ElectroCore (ECOR) United States $0.028B 0.00
Cardiome Pharma (CORV) Canada $0.025B 0.00
Jaguar Animal Health (JAGX) United States $0.025B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.024B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.024B 0.00
Mannatechorporated (MTEX) United States $0.023B 7.32
Adamis Pharmaceuticals (ADMP) United States $0.023B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.023B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
Lipocine (LPCN) United States $0.021B 0.00
India Globalization Capital (IGC) United States $0.018B 0.00
Bio-Path Holdings (BPTH) United States $0.017B 0.00
Novan (NOVN) United States $0.017B 0.00
Can-Fite Biopharma (CANF) Israel $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.012B 0.00
Cyanotech (CYAN) United States $0.012B 0.00
Shineco (TYHT) China $0.011B 0.00
KemPharm (KMPH) United States $0.011B 0.00
Vical (BBI) United States $0.011B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Regulus Therapeutics (RGLS) United States $0.010B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.008B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.006B 0.00
Midatech Pharma (MTP) United Kingdom $0.006B 0.00
HANCOCK JAFFE (HJLI) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
Flex Pharma (SLRX) United States $0.003B 0.00